Nomenclature for human CYP2D6 alleles

被引:382
|
作者
Daly, AK
Brockmoller, J
Broly, F
Eichelbaum, M
Evans, WE
Gonzalez, FJ
Huang, JD
Idle, JR
IngelmanSundberg, M
Ishizaki, T
JacqzAigrain, E
Meyer, UA
Nebert, DW
Steen, VM
Wolf, CR
Zanger, UM
机构
[1] HUMBOLDT UNIV BERLIN, INST KLIN PHARMAKOL, KLINIKUM CHARITE, D-10098 BERLIN, GERMANY
[2] CTR HOSP REG & UNIV LILLE, HOP CALMETTE, LAB BIOCHIM & BIOL MOL, F-59037 LILLE, FRANCE
[3] DR MARGARETE FISCHER BOSCH INST CLIN PHARMACOL, D-70376 STUTTGART, GERMANY
[4] ST JUDE CHILDRENS RES HOSP, DEPT PHARMACEUT, MEMPHIS, TN 38101 USA
[5] NCI, MOLEC CARCINOGENESIS LAB, NIH, BETHESDA, MD 20892 USA
[6] NATL CHENG KUNG UNIV, DEPT PHARMACOL, TAINAN 70101, TAIWAN
[7] KAROLINSKA INST, DEPT MED BIOCHEM & BIOPHYS, S-17177 STOCKHOLM, SWEDEN
[8] INT MED CTR JAPAN, RES INST, DEPT CLIN PHARMACOL, SHINJUKU KU, TOKYO 162, JAPAN
[9] HOP ROBERT DEBRE, INSERM U120, F-75019 PARIS, FRANCE
[10] HOP ROBERT DEBRE, DEPT CLIN PHARMACOL, F-75019 PARIS, FRANCE
[11] UNIV BASEL, BIOCTR, ABT PHARMAKOL, CH-4056 BASEL, SWITZERLAND
[12] UNIV CINCINNATI, MED CTR, DEPT ENVIRONM HLTH, CINCINNATI, OH 45267 USA
[13] HAUKELAND HOSP, CTR MOL MED, DR EINAR MARTENS RES GRP BIOL PSYCHIAT, N-5021 BERGEN, NORWAY
[14] UNIV DUNDEE, NINEWELLS HOSP & MED SCH, BIOMED RES CTR, DUNDEE DD1 9SY, SCOTLAND
来源
PHARMACOGENETICS | 1996年 / 6卷 / 03期
关键词
allele nomenclature; CYP2D6;
D O I
10.1097/00008571-199606000-00001
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
To standardize CYP2D6 allele nomenclature, and to conform with international human gene nomenclature guidelines, an alternative to the current arbitrary system is described, Based on recommendations for human genome nomenclature, we propose that alleles be designated by CYP2D6 followed by an asterisk and a combination of roman letters and arabic numerals distinct for each allele with the number specifying the key mutation and, where appropriate, a letter specifying additional mutations, Criteria for classification as a separate allele and protein nomenclature are also presented.
引用
收藏
页码:193 / 201
页数:9
相关论文
共 50 条
  • [31] Human CYP2D6 Is Functional in Brain In Vivo: Evidence from Humanized CYP2D6 Transgenic Mice
    Cole Tolledo
    Marlaina R. Stocco
    Sharon Miksys
    Frank J. Gonzalez
    Rachel F. Tyndale
    Molecular Neurobiology, 2020, 57 : 2509 - 2520
  • [32] Metoclopramide is metabolized by CYP2D6 and is a reversible inhibitor, but not inactivator, of CYP2D6
    Livezey, Mara R.
    Briggs, Erran D.
    Bolles, Amanda K.
    Nagy, Leslie D.
    Fujiwara, Rina
    Furge, Laura Lowe
    XENOBIOTICA, 2014, 44 (04) : 309 - 319
  • [33] Standard CYP2D6 genotyping procedures fail for the CYP2D6*5 and duplication alleles when hair roots are used as a source of DNA
    Gan, SH
    Ismail, R
    Adnan, WAW
    Wan, Z
    CLINICA CHIMICA ACTA, 2003, 329 (1-2) : 61 - 68
  • [34] FREQUENCY OF CYP2D6 ALLELES INCLUDING STRUCTURAL VARIANTS IN THE UNITED STATES
    Del Tredici, A. L.
    Malhotra, A.
    Dedek, M.
    Espin, F.
    Roach, D.
    Zhu, G. -D.
    Voland, J.
    Moreno, T. A.
    Gaedigk, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S26 - S26
  • [35] Frequency of CYP2D6 alleles among 749 patients with schizophrenia.
    Brockmöller, J
    Sachse, C
    Schmider, J
    Dettling, M
    Müller-Oerlinghausen, B
    Roots, I
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 128 - 128
  • [36] CYP2D6*3 and*4 alleles frequencies among Volga Tatars
    Garayeva, A.
    Kravtsova, O.
    Varfolomeev, A.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 1005 - 1005
  • [37] Response to CYP2D6 substrate antidepressants is predicted by a CYP2D6 composite phenotype based on genotype and comedications with CYP2D6 inhibitors
    Gressier, F.
    Verstuyft, C.
    Hardy, P.
    Becquemont, L.
    Corruble, E.
    JOURNAL OF NEURAL TRANSMISSION, 2015, 122 (01) : 35 - 42
  • [38] Frequency of CYP2D6 Alleles Including Structural Variants in the United States
    Del Tredici, Andria L.
    Malhotra, Alka
    Dedek, Matthew
    Espin, Frank
    Roach, Dan
    Zhu, Guang-dan
    Voland, Joseph
    Moreno, Tanya A.
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [39] CYP2D6 genotypes in a Japanese population:: low frequencies of CYP2D6 gene duplication but high frequency of CYP2D6*10
    Nishida, Y
    Fukuda, T
    Yamamoto, I
    Azuma, J
    PHARMACOGENETICS, 2000, 10 (06): : 567 - 570
  • [40] Effect of CYP2D6*2 and*10 alleles on metabolism of dextromethorphan and mefloquine.
    Flockhart, DA
    Macpherson, AS
    Gimenez, F
    Bendriss, K
    Na-Bangchang, K
    Markoglou, N
    Wainer, IW
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 100 - 100